Many females suffer from depression and for most they may not know what to do in the case of pregnancy. I for one wouldn’t know what the best route of action would be. Is it safer to continue mood stabling treatments or discontinue them during pregnancy?
This study assessed the danger of return of mood occurrences among women with a history of bipolar disorder that continued or stopped treatment with mood stabilizers during pregnancy.
In a prospective observational clinical cohort study, the authors determined recurrence risk and survival-analysis-based time to recurrence of a new episode in 89 pregnant women with bipolar disorder. Eligible subjects were euthymic at conception and continued ...view middle of the document...
Bipolar disorder affects 0.5%-1.5% of individuals within the United States. The usual age of onset is late teenage years or early adulthood, placing females at risk for episodes through their reproductive years. General treatment guidelines for bipolar disorder are accessible from the American Psychiatric Association.
A professional board studied articles that report the management of bipolar disorder and the significances of the use of mood stabilizers during pregnancy, and a consensus article was produced. The treatment of bipolar disorder in pregnant women involves substantial challenges.
Meanwhile treatment can be accomplished most effectively if their pregnancy is planned; clinicians should talk over the issues of pregnancy and its management options with every single bipolar disorder patient who has reached a child bearing age, regardless of their future reproductive ideas.
Viguera et al. (2007) associate relapse rates and time to recurrence for mood episodes between women who continued taking mood stabilizers during their pregnancy and those who stopped medication. The associates joined 89 women who had either bipolar I or bipolar II disorder who were planning pregnancy and looking for a psychiatric consultation in a specialized perinatal psychiatry program. Pregnant women were enrolled prior to 24 weeks gestation and were euthymic for at least 1 month before conception, were receiving treatment with a mood stabilizer, or had stopped pharmacotherapy for at least 6 months before pregnancy or within the first trimester. Females were monitored through pregnancy and there postpartum year. The patients decided on their own whether they wanted to continue or discontinue their medication. About 70.8% of women experienced at least one mood event during pregnancy. The risk of recurrence was considerably higher in women who decided to discontinue their treatment with mood stabilizers. Women who stopped medication also spent more time...